Literature DB >> 17893286

Acute ischemic stroke treatment in 2007.

Larry B Goldstein1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893286     DOI: 10.1161/CIRCULATIONAHA.106.670885

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  32 in total

Review 1.  Cell-based therapy for stroke.

Authors:  Yu Luo
Journal:  J Neural Transm (Vienna)       Date:  2010-10-14       Impact factor: 3.575

2.  Cleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor.

Authors:  Kay-Siong Ng; How-Wing Leung; Peter T-H Wong; Chian-Ming Low
Journal:  J Biol Chem       Date:  2012-05-18       Impact factor: 5.157

Review 3.  Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.

Authors:  Preeti Sahota; Sean I Savitz
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

4.  Exogenous and endogenous therapeutic effects of combination Sodium Ferulate and bone marrow stromal cells (BMSCs) treatment enhance neurogenesis after rat focal cerebral ischemia.

Authors:  Yonghua Zhao; Wan Lai; Youhua Xu; Liming Li; Zhenwei Chen; Weikang Wu
Journal:  Metab Brain Dis       Date:  2013-08-17       Impact factor: 3.584

5.  Effects of Tannic Acid on the Ischemic Brain Tissue of Rats.

Authors:  Halil Murat Sen; Adile Ozkan; Mustafa Guven; Tarık Akman; Adem Bozkurt Aras; Ibrahim Sehitoglu; Hasan Alacam; Coskun Silan; Murat Cosar; Handan Isın Ozisik Karaman
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

6.  Salidroside-Mediated Neuroprotection is Associated with Induction of Early Growth Response Genes (Egrs) Across a Wide Therapeutic Window.

Authors:  Wenfang Lai; Zhenwei Zheng; Xiaoqin Zhang; Yicong Wei; Kedan Chu; John Brown; Guizhu Hong; Lidian Chen
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 7.  Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.

Authors:  Rao Muralikrishna Adibhatla; James F Hatcher
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

8.  Treatment with LXR agonists after focal cerebral ischemia prevents brain damage.

Authors:  Luigi Sironi; Nico Mitro; Mauro Cimino; Paolo Gelosa; Uliano Guerrini; Elena Tremoli; Enrique Saez
Journal:  FEBS Lett       Date:  2008-09-19       Impact factor: 4.124

9.  Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke.

Authors:  Tauheed Ishrat; Bindu Pillai; Adviye Ergul; Sherif Hafez; Susan C Fagan
Journal:  Neurochem Res       Date:  2013-11-06       Impact factor: 3.996

10.  Delayed treatment with a p53 inhibitor enhances recovery in stroke brain.

Authors:  Yu Luo; Chi-Chung Kuo; Hui Shen; Jenny Chou; Nigel H Greig; Barry J Hoffer; Yun Wang
Journal:  Ann Neurol       Date:  2009-05       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.